Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis
NCT07918339, Not applicable, Recruiting, Cairo University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis | ClinicalTrials.gov |
| NCT number | NCT07918339 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 54 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Cairo University | ClinicalTrials.gov |
| Conditions | Multiple Sclerosis | ClinicalTrials.gov |
| Interventions | Mental Practice, Virtual Reality, Selected Physical Therapy Program | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-05 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Gait | 6 weeks | spatial, temporal and angular parameters as cadence, step length and range of motion of hip, knee and ankle will be measured using software analysis "Kinovea" Kinovea is a free, open-source 2D video analysis software. It does not generate a single composite "score". Instead, it measures quantitative biomechanical and kinematic metrics from recorded video. | ClinicalTrials.gov |
| Primary | Gait | 6 weeks | "10 minutes walk test" will be performed pre and post treatment by asking the patient to walk through a 12 meter walkway and calculate the time for 10 meters in tha walkway in two walking speeds( normal - fast) for 2 or 3 trials of each speed Speed \> 1.2 m/s: Normal / Community AmbulatorAble to safely cross street intersections and navigate crowded environments. 0.8 - 1.2 m/s: Limited Community Ambulator/ Able to walk outdoors independently 0.4 - 0.8 m/s: Household Ambulator/ Mostly restricted to indoor walking; requires assistance or equipment outdoors. \< 0.4 m/s: Severe Functional Limitation | ClinicalTrials.gov |
| Primary | Balance | 6 weeks | static and dynamic balance will be assessed using "Berg Balance Scale" The Berg Balance Scale (BBS) is a 14-item clinical assessment scale designed to measure static balance and dynamic functional mobility, Point Scale: Each of the 14 tasks is rated on a 0 to 4 ordinal scale based on safety, independence, time held, or distance reached, Scores are summed across all items for a overall score ranging from 0 to 56 points (higher scores reflect better balance and mobility). | ClinicalTrials.gov |
| Primary | Balance | 6 weeks | "Timed Up and Go" test giving numerical data pre and post treatment about balance and risk of falling Test is scored entirely by time (in seconds): Time \< 10 seconds: Normal / Completely IndependentFreely mobile; minimal to no fall risk 10 - 19 seconds: Mostly Independent, Reasonable balance and gait speed, generally low fall risk 20 - 29 seconds: Variable MobilityImpaired mobility, slower gait speed \> 30 seconds: Severely Impaired, high fall risk | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)